Recombinant Mycobacterium bovis Bacillus Calmette-Guérin Elicits Human Immunodeficiency Virus Type 1 Envelope-Specific T Lymphocytes at Mucosal Sites

A successful vaccine vector for human immunodeficiency virus type 1 (HIV-1) should induce anti-HIV-1 T-cell immune responses at mucosal sites. We have constructed recombinant Mycobacterium bovis bacillus Calmette-Guérin (rBCG) expressing an HIV-1 group M consensus envelope (Env) either as a surface,...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Yu, Jae-Sung, Peacock, James W., Jacobs, William R., Frothingham, Richard, Letvin, Norman L., Liao, Hua-Xin, Haynes, Barton F.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology (ASM) 2007
Matèries:
Vaccine Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC1951062/
https://ncbi.nlm.nih.gov/pubmed/17507541
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CVI.00407-06
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars